Greiner Stacy
Known title: DirectorCIK: 0001894943
Associated companies
Transaction History
| PRLB | ▲ Buy | Grant | 3,939 | $0 | 5/23/2025 | View on chart |
| PRLB | ▲ Buy | Grant | 4,701 | $0 | 5/23/2024 | View on chart |
| PRLB | ▲ Buy | Grant | 4,513 | $0 | 5/17/2023 | View on chart |
| PRLB | ▲ Buy | Grant | 3,236 | $0 | 8/30/2022 | View on chart |
| PRLB | ▲ Buy | Grant | 3,236 | $0 | 5/18/2022 | View on chart |
| PRLB | ▲ Buy | Grant | 767 | $0 | 11/15/2021 | View on chart |
| PRLB | ▲ Buy | Grant | 2,488 | $0 | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Proto Labs to Host Q3 2026 Earnings Call
Proto Labs has announced a conference call to discuss its third-quarter 2026 financial results. This upcoming event will provide investors with the latest update on the company’s performance and outlook. The stock currently trades within a wide 52-week range, reflecting recent volatility.
Proto Labs to Host Q3 2026 Earnings Call. Proto Labs has announced a conference call to discuss its third-quarter 2026 financial results. This upcoming event will provide investors with the latest update on the company’s performance and outlook. The stock currently trades within a wide 52-week range, reflecting recent volatility.